Alzamend Neuro, Inc. Common Stock (ALZN) is a publicly traded Healthcare sector company. As of July 22, 2026, ALZN trades at $1.34 with a market cap of $4.79M and a P/E ratio of -0.12. ALZN moved +5.56% today. Year to date, ALZN is -27.47%; over the trailing twelve months it is -59.51%. Its 52-week range spans $0.84 to $12.06. Rallies surfaces ALZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ALZN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.34 |
| Market Cap | $4.79M |
| P/E Ratio | -0.12 |
| EPS | $-11.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.06 |
| 52-Week Low | $0.84 |
| Volume | 66.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $4.50M |
| Gross Margin | 0.00% |
ALZN analyst coverage data. Average price target: $0.00.